Applied Spine Technologies, Inc. www.appliedspine.com, a medical device company focused on motion preservation of the lumbar spine, received a Notice of Allowance on July 12, 2010 from the U.S. Patent and Trademark Office.
“To be clinically useful, a dynamic stabilization device needs to allow the spine to move, but not move excessively”
The application, titled 'Dynamic spine stabilization device with travel-limiting functionality' (U.S. application No. 11/189,512), describes the use of a travel limiting feature as part of a flexible spinal stabilization device.
"To be clinically useful, a dynamic stabilization device needs to allow the spine to move, but not move excessively," said Bruce Robie, PhD, Vice President of Research and Development for Applied Spine. "This Notice of Allowance protects a class of devices that enable motion, like our Stabilimax device, and include structure to protect against the device moving excessively."
"This Notice demonstrates further evidence of our ever maturing Intellectual Property," said Craig Corrance, President and CEO of Applied Spine. "The Company constantly manages its I.P. portfolio in order to protect and differentiate our Stabilimax platform while also working closely with its I.P. Counsel to ensure continuation of patent grants, both near term and in the years ahead."
Tiam1 inhibition mitigates morphine tolerance and hyperalgesia in mouse model